← back to search

Bai‐Yu Lee

University of California, Los Angeles · US
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Bacillus and Francisella bacterial research, Tuberculosis Research and Epidemiology, Bacterial Genetics and Biotechnology, and Bacteriophages and microbial interactions.
h-index
26
citations
2,863
works
45
NIH funding
primary concept
email

Recent publications

The Francisella Type VI Secretion System
Frontiers in Cellular and Infection Microbiology 2018cited by 73position: middledoi
Facile Strategy Enabling Both High Loading and High Release Amounts of the Water-Insoluble Drug Clofazimine Using Mesoporous Silica Nanoparticles
ACS Applied Materials & Interfaces 2018cited by 64position: middledoi
A Pathogen-Specific Cargo Delivery Platform Based on Mesoporous Silica Nanoparticles
Journal of the American Chemical Society 2017cited by 70position: middledoi
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time
Nature Communications 2017cited by 67position: firstdoi
Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model
Proceedings of the National Academy of Sciences 2016cited by 91position: middledoi
Redox‐Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap‐Tops Enhances Efficacy Against Pneumonic Tularemia in Mice
Small 2016cited by 86position: firstdoi
Massively parallel delivery of large cargo into mammalian cells with light pulses
Nature Methods 2015cited by 174position: middledoi
Atomic Structure of T6SS Reveals Interlaced Array Essential to Function
Cell 2015cited by 160position: middledoi
Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia
ACS Nano 2015cited by 122position: middledoi
pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice
Small 2015cited by 90position: middledoi
Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
Antimicrobial Agents and Chemotherapy 2012cited by 253position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel L. Clemens · University of California, Los Angeles11 papers (2012–2018)Marcus A. Horwitz · University of California, Los Angeles11 papers (2012–2018)Jeffrey I. Zink · University of California, Los Angeles6 papers (2012–2018)Barbara Jane Dillon · University of California, Los Angeles4 papers (2015–2017)Aleidy Silva · University of California, Los Angeles2 papers (2016–2017)Xianting Ding · XinHua Hospital2 papers (2016–2017)Zilu Li · Zhejiang Sci-Tech University2 papers (2015–2016)Chih‐Ming Ho · Fu Jen Catholic University2 papers (2016–2017)Angela Hwang · St Vincent's Hospital Sydney2 papers (2015–2016)André E. Nel · California NanoSystems Institute1 papers (2012–2012)Min Xue · California Institute of Technology1 papers (2012–2012)Chi‐An Cheng · National Taiwan University1 papers (2018–2018)Theodore Kee · National University of Singapore1 papers (2016–2016)Daniel P. Ferris · Allen Institute for Brain Science1 papers (2012–2012)Pei‐Yu Chiou · University of California, Los Angeles1 papers (2015–2015)Wei Chen · Brigham and Women's Hospital1 papers (2018–2018)Huan Meng · Jiangsu University1 papers (2012–2012)P. Ge · Howard Hughes Medical Institute1 papers (2015–2015)Ting‐Hsiang Wu · Westwood College1 papers (2015–2015)Wen-Yen Huang · National Cheng Kung University1 papers (2018–2018)